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Materials and Methods 
Protein expression and purification. DNA fragments encoding full-length Sec13, 
Nup145C (residues 75-712), full-length Seh1, and Nup85 (44-744) were PCR amplified 
and cloned as pairs into the pET-Duet1 expression vector (Novagen). Nup145C and 
Nup85 were cloned into the first multiple cloning site using BamHI and NotI restriction 
sites, whereas Sec13 and Seh1 were cloned into the second multiple cloning site using 
NdeI and XhoI restriction sites. Nup84 (residues 1-451) was cloned into a modified 
pET28a vector, which contains an N-terminal hexahistidine tag followed by a PreScission 
protease cleavage site, using NdeI and NotI restriction sites (18). The expression 
construct for Nup120 was described previously (2). The selected synthetic antibody 
(sAB) fragments of sAB-57 and sAB-87 were cloned into the pSFV4 vector (Peter 
Loppnau, Structural Genomics Consortium, University of Toronto) using the restriction 
sites NcoI and SalI, and subsequently digested using SalI and BsaI and religated to obtain 
the C-terminal hexahistidine tag. The details of the bacterial expression constructs are 
listed in table S1. 
All proteins were expressed in Escherichia coli BL21-Codon-Plus (DE3)-RIL cells 
(Stratagene) in Luria-Bertani media. Seleno-L-methionine-labeled (SeMet) 
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NTD were produced in a synthetic medium that 
suppresses methionine biosynthesis, following standard protocols. For all nucleoporins, 
expression was induced at an OD600 of 0.8 with 0.5 mM isopropyl-β-D-
thiogalactopyranoside (IPTG), followed by growth at 18 °C for 18 hours. Cells were 
harvested by centrifugation and resuspended in a buffer containing 20 mM TRIS (pH 
8.0), 500 mM NaCl, 20 mM imidazole, 4 mM β-mercaptoethanol (β-ME), and complete 
EDTA-free protease inhibitor mixture (Roche). 
For purification, cells were lysed with a cell disruptor (Avestin) and DNase I 
(Roche) was added to the lysate before centrifugation at 30,000 × g for 1 hour. The 
supernatant was filtered through a 0.45-µm filter (Millipore) and loaded onto a nickel-
nitrilotriacetic acid (Ni-NTA) column (Qiagen) equilibrated in 20 mM TRIS (pH 8.0), 
500 mM NaCl, 20 mM imidazole, and 4 mM β-ME. Protein was eluted with a linear 
gradient of 20 mM TRIS (pH 8.0), 500 mM NaCl, 500 mM imidazole, and 4 mM β-ME. 
Protein-containing fractions were pooled, incubated with either PreScission (GE 
Healthcare) or ULP1 protease, and dialyzed overnight at 4 °C against a buffer containing 
20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. Next the protein was loaded onto 
a Mono Q 10/100 GL ion-exchange column (GE Healthcare) equilibrated in a buffer 
containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT and eluted using a 
NaCl gradient. Protein-containing fractions were concentrated in a centrifugal filter 
(Millipore) and loaded onto a HiLoad Superdex 200 16/60 gel filtration column (GE 
Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 
and 5 mM DTT. Protein-containing fractions were pooled and concentrated to 20 mg/mL 
for biochemical interaction experiments and CNC reconstitution. 
sABs were expressed, harvested, and lysed in a similar fashion, but the cells were 
induced at an OD600 of 0.9 with 0.25 mM IPTG and grown at 25 °C for 18 hours. After 
lysis, the lysate was incubated at 65 °C for 30 minutes and then cooled on ice for 15 
minutes before centrifugation. Protein-containing fractions from the Ni-NTA affinity 
purification were pooled and loaded onto a 5 mL HiTrap MabSelect SuRe column (GE 
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Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 20 
mM imidazole, and 4 mM β-ME. The protein was eluted using a linear gradient of an 
elution buffer, containing 0.1 M sodium citrate (pH 3.2). To rapidly increase the pH after 
elution, the fractions were collected into tubes containing 200 µl of 1 M TRIS (pH 9.0). 
The eluted fractions were dialysed against a buffer containing 20 mM TRIS (pH 8.0) and 
100 mM NaCl and concentrated to 10 mg/ml for biochemical interaction experiments and 
crystallization. 
 
Reconstitution of CNC complexes. '47
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was mixed with a 1.2 fold molar excess of Nup84NTD, incubated on ice for 30 minutes, 
and loaded onto a HiLoad Superdex 200 16/60 gel filtration column equilibrated in a 
buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. Trimer1 and 
Trimer2 containing fractions were pooled, concentrated, mixed with a 1.2 molar excess 
of Trimer2, incubated on ice for 1 hour, and injected onto a HiLoad Superdex 200 16/60 
gel filtration column equilibrated in the same buffer. Fractions containing the 
reconstituted CNC were pooled and concentrated to 10 mg/ml for sAB interaction 
experiments. For SeMet labeled CNC, SeMet-;014;43'47
N"D?'42
N"D?
0=3
Nup84NTD were purified and used instead of the native proteins. SeMet labeling of 
Nup120 rendered the protein insoluble in our bacterial expression system and thus native 
Nup120 was used for the reconstitution of the SeMet-labeled CNC. For the generation of 
"NB 2><?;4G4B =0C8E4 >A '4Met-labeled CNC were mixed with 1.5 fold molar 
excess of sAB-57 or a 1:1 mixture of sAB-57 and sAB-87 and loaded onto a HiLoad 
Superdex 200 16/60 gel filtration column (GE Healthcare) equilibrated in a buffer 
containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. DTT was included in 
the buffer as it was necessary for CNC stability and had no effect on the integrity of the 
sABs. Fractions containing the various CNC complexes were pooled and concentrated to 
10 mg/mL for crystallization. 
 
sAB selection and characterization. The generation and screening of conformation-
specific sABs has been described previously (5). Briefly, a modified yeast CNC was 
reconstituted with a Nup84NTD variant that harbored an N-terminal avi-tag. The complex 
was biotinylated in a 2 mL reaction by incubating 40 µM protein with a buffer containing 
50 mM BICINE (pH 8.3), 100 mM biotin, 10 mM ATP, 10 mM magnesium acetate, and 
30 µg biotin ligase (BirA) at 30 °C for 2 hours. After labeling, protein was buffer 
exchanged using a 5 mL HiTrap Desalting column (GE Healthcare) equilibrated with a 
buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT and purified 
again using a HiLoad Superdex 200 16/60 gel filtration column equilibrated in the same 
buffer. The extent of Nup84NTD biotinylation and efficiency of capture were tested by 
incubating 25 µg of protein with 50 µL of Streptavidin MagneSphere particles (Thermo 
Scientific), washing once with 50 µL of a buffer containing 20 mM TRIS (pH 8.0), 100 
mM NaCl, and 5 mM DTT, and resolving the bound proteins on a SDS-PAGE gel. Four 
rounds of competitive selection were performed using 100 nM (round 1), 50 nM (round 
2), 10 nM (round 3), and 10 nM (round 4) biotinylated protein target and a phage display 
library according to previously published protocols (5). In case of sAB-57 biotinylated 
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yeast CNC was used and to eliminate sABs that recognized unassociated CNC 
components, 1 µM of non-18>C8=H;0C43 " BD1D=8CB '47
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	NTD, 
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NTD) were used as competitors in all solutions during the last 
three rounds of selection. Phages were preincubated with competitors for 1 hour at room 
temperature. sAB-87 was obtained in a selection where biotinylated Nup120NTD was used 
and no competition was performed. After successful selection, the specificity of 
candidate sABs was tested against the assembled biotinylated yeast CNC, as well as 
individual biotinylated subunits using a single point competitive ELISA assay (5). Only 
sequence-unique sABs with the desired binding properties were nominated for further 
biochemical characterization. To evaluate the binding affinity and specificity of the 
selected sABs, 1.5-fold molar excess of sAB was incubated with the reconstituted CNC 
or individual CNC components and loaded onto a MonoQ 5/50 GL ion-exchange column 
(GE Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM 
NaCl, and 5 mM DTT and eluted using a NaCl gradient. Interacting sABs eluted with the 
CNC components, whereas non-interacting sABs eluted prior to the gradient step. 
Initially, only sABs that specifically interacted with the fully assembled CNC were 
systematically tested in crystallization trials. To improve the diffraction properties of the 
"NB-57 crystals, additional sABs with the ability to bind individual CNC 
components were systematically screened for crystal formation. The addition of sAB-87 
C> C74 "NB-57 complex yielded a new crystal form with distinct packing and 
different space group. 
 
Protein crystallization, heavy metal derivatization and data collection. Protein 
crystallization was carried out at 21 °C in hanging drops consisting of 1.0 µL protein 
solution (2 mg/ml) and 1.0 µL reservoir solution. Crystals appeared in the monoclinic 
space group C2 with one co?H>5C74"NB-57 complex in the asymmetric unit. The 
crystals were improved by microseeding, which resulted in crystals that grew as thin 
plates with maximum dimensions of ~30×300×300 µm3 within 1 week. Crystals used for 
diffraction experiments were grown in 0.1 M MES, pH 6.7, 5 % (w/v) PEG 20000, and 
3% (v/v) ethanol. Crystals were cryoprotected by gradually supplementing the drop with 
36 % (v/v) ethylene glycol (in 1 % steps, every 5 minutes) and flash frozen in liquid 
nitrogen. Crystals of the CNC changed morphology after the inclusion of a second sAB 
(sAB-87) and appeared in the orthorhombic space group P212121 with one copy of the 
"NB-NB-87 complex in the asymmetric unit. Crystals grew to maximum 
dimensions of ~50×100×150 µm3 within 1 week. Crystals used for diffraction 
experiments were grown in 0.1 M MES, pH 6.5, 5 % (w/v) PEG 20000, and 20 mM 
SrCl2. Crystal were cryoprotected by serial transfers into solutions containing 5 %, 10 %, 
15 %, 20 % and 25 % (v/v) ethylene glycol supplemented reservoir solution. This crystal 
form typically diffracted to a resolution limit of ~9 Å. During a systematic heavy metal 
derivative screen individual SeMet labeled crystals were identified that yielded X-ray 
diffraction data to a resolution limit of 7.6 Å after soaking with 1 mM potassium 
hexachloroosmate (K2OsCl6). Native crystals were derivatized by adding 0.2 µL of a 
saturated tantalum bromide cluster (Ta6Br14) solution to the crystallization drop and 
incubated for 1 week. X-ray diffraction data were collected at 100 K at beamline BL12-2 
at the Stanford Synchrotron Radiation Source (SSRL) and beamline GM/CA-CAT 23ID-
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D at the Advanced Photon Source (APS) on a Pilatus3 detector. Thousands of CNC 
crystals were screened to yield the reported X-ray diffraction datasets. 
 
Structure determination and model building. X-ray diffraction data was processed 
with XDS (19). The structures for both crystal forms were solved by iterative cycles of 
molecular replacement (MR) using Phaser (20). 
>A BCAD2CDA4 34C4A<8=0C8>= >5 C74 58ABC 2AHBC0; 5>A< 2>=C08=8=6 C74 "NB-57 
complex in the space group C2, Phaser was run with the assumption that the asymmetric 
unit (ASU) harbored one CNCNsAB-57 complex (~450 kDa), corresponding to a solvent 
content of ~83 %. The crystal structures of the S. cerevisiae CNC components 
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N"D?NTD (PDB ID 3F3F), Nup120NTD (PDB 
ID 3F7F), Nup84NTD (PDB ID 3IKO), and a structure of the sAB scaffold (PDB ID 
3PGF) were used sequentially as search models with a model variance of 100 % sequence 
identity (6-10). MR was performed in the above search order and the top solutions were 
taken from each MR search to look for the next molecule. During each MR round, Phaser 
robustly obtained solutions with clear separation from other solutions after the packing 
test with Log Likelihood Gain (LLG) values and refined translation function Z-scores 
(. >5 
    (.	 '42
N"D?
NTD), (2) LLG=94, TFZ=11.6 
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N"D?NTD), (3) LLG=190, TFZ=6.9 (Nup120NTD), (4) LLG=202, TFZ=8.1 
(Nup84NTD), and (5) LLG=310, TFZ=8.5 (sAB scaffold) (fig. S1A, B). 
The correctness of the final solution output from Phaser was assessed on the 
following criteria: (1) clear separation of the best scoring solutions from the remaining 
solutions at every step, (2) very high TFZ scores after each step, as TFZ scores above 8 
usually indicate a definite solution, (3) increasing LLG scores at each step indicating that 
each additional molecule was improving the solution, (4) an internal test that the 
Nup84NTD was placed in the same orientation as previously determined in the 
'42
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NTD crystal structure (8), despite no a priori information 
restricting it to that location, (5) the overall shape of the solution was consistent with low 
resolution EM reconstructions, and most importantly (6) the appearance of strong 
additional features in the calculated electron density maps of the final solution. Strong 
positive difference density for the helices of the triskelion were clearly visible in the |Fo|-
|Fc| map output from PHENIX (fig. S2A). Density modification of the MR solution using 
RESOLVE (21) yielded an improved electron density map with additional density for 
loops connecting the new helices despite no additional model building (fig. S2A). 
Furthermore, no additional density was observed in the solvent channels (fig. S4A). 
Model building was performed with COOT (22). The α-helical C-terminal domains of 
Nup145C, Nup85, and Nup120 formed distinctive arrays of tubular electron density at 
7.4 Å, into which we were able to place idealized α-helices. As the C-terminal domains 
of Nup145C, Nup85, and Nup120 are connected to their respective N-terminal domains 
by short loops, a preliminary model for the connectivity and directionality of the helices 
was traced starting from the C-terminus of each previously determined structure. This 
preliminary model was validated by comparison with the helical arrangement in the S. 
pombe homolog of Nup120, which could be structurally aligned with the helices assigned 
to the C-terminal domain of Nup120. Once all of the helices were successfully assigned 
to each protein, the connectivity of all three proteins could be assigned with the aid of the 
helix and loop lengths from a secondary structure prediction (fig. S3D). As the electron 
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density does not possess features to assign the sequence register, the numbering in the 
structure is approximate and only reflects the order and directionality of each helix and 
thus we modeled the triskelion with the sidechains truncated at the Cβ position. 
>A BCAD2CDA4 34C4A<8=0C8>= >5 C74 B42>=3 2AHBC0; 5>A< 2>=C08=8=6 C74"NB-
NB-87 complex, which grew in the space group P212121, sequential Phaser searches 
5>A C74 '42
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NTD heterotrimer (PDB ID 3IKO), Nup120NTD (PDB 
ID 3F7F), and the sAB scaffold structure (PDB ID 3PGF) produced clearly separated 
solutions with the following scores: (1) LLG=239, TFZ=13.3 
'42
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NTD), (2) LLG=653, TFZ=12.2 (Nup120NTD), and (3) 
LLG=887, TFZ=11.2 (sAB scaffold, sAB-87) (fig. S1C, D). Despite exhaustive attempts 
with both the normal Phaser pipeline and brute-force translation and rotation searches, no 
!& B>;DC8>=B F4A4 834=C85843 5>A '47
N"D?NTD (PDB ID 3F3F) and a second sAB 
scaffold (PDB ID 3PGF) for sAB-57 and these molecules are likely disordered in the 
crystal. The resulting maps were comparable in quality to those of the C2 crystal form 
(fig. S2B). The arrangement of Sec13, Nup145CNTD, Nup84NTD, and the Nup120NTD in 
C74 58=0;!&B>;DC8>= 8B C74B0<40B C70C 8= C74BCAD2CDA4>5 C74"NB-57 complex 
(fig. S6). The correctness of the solution was confirmed by the calculation of an 
anomalous difference Fourier map using the phases from the MR solution, which 
revealed peaks for 20 selenium sites and 1 Os site (fig. S3A-C). Improved phases were 
obtained with MR-SAD in Phaser using phases from the MR solution and the 21 
anomalous scatterers. Subsequent density modification revealed clear tubular density for 
the triskelion helices, including density for the Nup85CTD, which could be readily docked 
8= C74 B0<4 2>=5>A<0C8>=B 0B >1B4AE43 8= C74 "NB-57 structure. Additional 
confirmation of the correctness of the solution was obtained by calculating an anomalous 
difference Fourier map using anomalous X-ray diffraction data obtained from a 
"NB-NB-87 complex crystal derivatized with Ta6Br14, which revealed 8 
tantalum bromide cluster sites (fig. S3A-C). 
Of the 20 selenium peaks observed, 11 aligned with the expected selenium sites in 
the previously determined structures of Nup84NTD and '42
NNup145CNTD. An additional 
8 selenium peaks were present in the newly built helices of Nup85CTD and Nup145CCTD, 
which were used to confirm the directionality and approximate sequence assignment of 
the helices. The final selenium site aligned with the last methionine present in Nup85NTD, 
but no additional sites were observed for th4 A4<08=34A >5 C74 '47
N"D?NTD 
heterodimer (fig. S3A">0338C8>=0;4;42CA>=34=B8CHF0BE8B81;45>A'47
N"D?NTD in 
density modified maps either, despite room being available in the lattice to accommodate 
the molecules (fig. S4B). Thus, this part of the structure is presumed to be disordered in 
this crystal form. 
 
Structure refinement. Refinement of both structures was performed with heavy 
restraints using PHENIX, with 1 group B-factor per residue with similarity restraints and 
positional refinement with secondary structure restraints and reference model restraints 
for the portions of the structure for which there were high-resolution structures (23). We 
elected to use models re-refined by the PDB_REDO server, as they had superior 
geometrical parameters to the previously deposited structures (24). The best strategy for 
B-factor refinement was determined by comparing the results of test refinements using 
the following strategies: 1 B-factor per residue with similarity restraints, 2 B-factors per 
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residue with similarity restraints, 1 B-factor per group, and 1 B-factor per group with 
TLS parameters (fig. S5A, B). We additionally tested the output of a refinement strategy 
of 1 B-factor per residue without similarity restraints to ensure that B-factors were 
meaningfully restrained. Refinement with 1 B-factor per residue with similarity restraints 
yielded the lowest R-factors and realistic B-factors that were smoothly distributed across 
the model (fig. S5B). Therefore, we elected to use that strategy with no TLS parameters 
for the final refinement. The final models of the C2 and P212121 crystal forms yielded 
average B factors for the overall model of 716.5 Å2 and 536.5 Å2, respectively, with 
comparable B factors for all protein chains (fig. S5D, E). These B-factors include the 
overall B of the crystal, as is the standard method of reporting B-factors in PHENIX. The 
resolution limits for both data sets were determined by using the paired refinement 
technique described by Karplus and Diederichs (25). Paired refinements were performed 
in 0.2 Å steps from 8.0 Å to 7.0 Å and the resolution limits were selected conservatively 
before resolution steps that did not improve the model (fig. S5F, G). The final models of 
the C2 and P212121 crystal forms, refined to a 7.4-Å and a 7.6-Å resolution, yielded Rfree 
and Rwork values of 35.3 %, 33.0 %, and 34.7 %, 31.8 %, respectively. The 
stereochemical properties of the two structures were determined by MolProbity (26). The 
CNC complex structures reported here have similar Ramachandran statistics as the search 
<>34;B DB43 5>A '42
N"up145CNTDN"D?NTD '47
NNup85NTD, and Nup120NTD. The 
newly built triskelion has perfect stereochemical parameters with no residues in the 
disallowed region of the Ramachandran plot. For details of the data collection and 
refinement statistics see table S2. 
 
Analytical size-exclusion chromatography. Protein-protein interaction experiments 
were carried out on a Superdex 200 10/300 GL gel filtration column equilibrated in a 
buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. The various 
combinations of the yeast CNC components were mixed and incubated for 30 minutes on 
ice using a 1.2 molar excess of the smaller proteins. Complex formation was monitored 
by injection of the pre-incubated proteins or the individual components onto the gel 
filtration column. All proteins were analyzed under identical buffer conditions and 
complex formation was confirmed by SDS-PAGE of the protein-containing fractions, 
followed by Coomassie brilliant blue staining. 
 
EM docking. The crystal structure of the yeast CNC was docked into the negative stain 
EM reconstructions of the yeast complex (EMDB-5151) and the human complex 
(EMDB-2443) using the Fit in Map function in the UCSF Chimera software package 
(27). 
The crystal structure of the yeast CNC was docked into the cryoelectron EM 
tomographic reconstruction of the human NPC (EMDB-2444) using an exhaustive, 
unbiased six-dimensional search using a Cα trace of the CNC structure with the program 
ESSENS from the Uppsala Software Factory package RAVE (28). The rotations were 
sampled in 10° steps across α, β, and γ for a total of 26,011 rotations, which were each 
tested at all of the 366,980 grid points which had a map value greater than 1.5. Each 
combination of rotation and grid point was scored by the K-minimum sum function over 
the lowest scoring 60 % of the atoms against the average of the 8 nearest grid points, as 
implemented in ESSENS (28). This exhaustive scoring method produced a clear 
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separation of 65 top scoring placements from the remaining orientations (fig. S12A). The 
positioning of the top 65 placements in the EM reconstruction was further refined and 
rescored using an orthogonal scoring method with the Fit in Map tool of UCSF Chimera 
(27), which we used to calculate the cross-correlation of the EM map with a simulated 
map calculated at 34 Å for each docked model (fig. S12B). 
Analysis of these solutions and their placements revealed a clear separation between 
the top 32 solutions and the remainder of solutions. Because of the eight-fold rotational 
symmetry in the map, unique solutions are each composed of 8 solutions related by 
rotational symmetry. As a result, the top 32 solutions form four unique rings, all of which 
are compatible when simultaneously placed into the NPC. The remaining solutions could 
be classified as one of the following: (1) solutions that refined into one of the above 
orientations upon refinement, (2) solutions with moderate scores lower than the top 
scoring 32 orientations and could be discarded due to clashes (fig. S12C), or (3) low 
scoring solutions that yielded much worse fits than the top 32 solutions upon refinement. 
Despite the presence of additional features in the map for cytoplasmic filament 
nucleoporins and associated mRNA export factors, the two CNC rings on the cytoplasmic 
face and the two CNC rings on the nucleoplasmic face are identical (fig. S12D). This 
additional unbiased test was taken as final confirmation that this stoichiometry and 
orientation of CNCs reflects their organization in the NPC. 
 
Illustration and figures. Structural figures were generated using PyMOL 
(www.pymol.org). 
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Fig. S1. 
Structure determination statistics of the yeast CNC. (A) Table of statistics for each 
step of molecular replacement performed using Phaser for structure determination of the 
CNCNsAB-57 complex. Each sequential step was performed with the top solutions from 
the previous step, and a clear separation of the top solutions was apparent with each step. 
(B) Plots of the initial log-likelihood gain (LLG) scores for the top 10 peaks from the 
translation function step of Phaser for structure determination of the CNCNsAB-57 
complex. (C) Table of statistics for each step of molecular replacement performed using 
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Phaser for structure determination of the CNCNsAB-57NsAB-87 complex. Each sequential 
step was performed with the top solutions from the previous step, and a clear separation 
of the top solutions was apparent with each step. (D) Plots of the initial log-likelihood 
gain (LLG) scores for the top peaks from the translation function step of Phaser for 
structure determination of the CNCNsAB-57NsAB-87 complex. For each step, there were 
only a handful of peaks selected from the rotation function, resulting in fewer peaks in 
the translation function. 
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Fig. S2 
Electron density during structure determination of the yeast CNC. The electron 
density for the initial molecular replacement and after density modification for the crystal 
structures of the (A) CNCNsAB-57 and (B) CNCNsAB-57NsAB-87 complexes are shown. 
Clear density was visible for the triskelion helices after successful placement of 
previously solved crystal structures (left) and remained after density modification (right), 
which was performed prior to model building. The models visualized are the direct output 
from molecular replacement prior to any interpretation.  
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Fig. S3. 
/$"3*/. /' "./-",/42 2$"33&1&12 *. $1823",2 /' 3)&;2-;2-87 complex. 
Anomalous difference Fourier maps were calculated for X-ray diffraction data collected 
0CC74B4;4=8D<0=3C0=C0;D<?40:F0E4;4=6C7B5>A"NB-NB-87 crystals grown 
with SeMet labeled protein and soaked with K2OsCl6 >A =0C8E4 "NB-NB-87 
crystals soaked with tantalum bromide clusters (Ta6Br14). (A) A ribbon representation of 
C74 BCAD2CDA4 >5 C74 "NB-NB-87 complex, with the anomalous difference 
Fourier maps of X-ray diffraction data collected at the selenium (purple) or tantalum 
(blue) peak wavelengths contoured at 3.5 σ and 4.5 σ, respectively. Tantalum peaks 
adjacent to Nup85NTD and a peak corresponding to the last selenium site in Nup85NTD are 
visible despite the molecule being disordered in the crystal. (B) Close-up view of 
selenium sites present for the triskelion helices for which there are no high-resolution 
structures. 8 peaks are visible and confirm the positioning and orientation and 
approximate sequence assignment in the structure. (C) Close-up view of the selenium 
peaks in Nup84NTD and Nup145C, with stick representations of the SeMet residues 
highlighting the expected sites. (D) Sequence and secondary structure prediction of 
Nup145CCTD and Nup85CTD with methionine residues highlighted. 
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Fig. S4. 
Crystal packing in crystals of CNC;2-57 and ;2-;2-87. 
Representative views of the crystal packing for crystals of the CNCNsAB-57 complex (A) 
and CNCNsAB-57NsAB-87 complex (B). (left) Uncarved density-modified electron 
density contoured at 1 σ demonstrates the large solvent channels present in both crystals. 
(center) Ribbon representation of the asymmetric unit and surrounding symmetry mates 
colored gray highlights a major crystal contact made in both crystals by a synthetic 
antibody with the Nup145CNNup84NTD interface. (right) Combined view of both the 
electron density and unit cell. 
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Fig. S5. 
Determination of optimal refinement strategy, resolution limits, and B-factor 
analysis. (A) Ribbon representations of the CNCNsAB-57 complex colored from blue to 
red by B-factor for various alternative refinement strategies with histograms of the B-
factor distribution below. (B) Ribbon representation of the CNCNsAB-57 complex refined 
with the final refinement strategy of 1 B-factor per residue and colored on the same scale 
as in (A). (C) Ribbon representation of the CNCNsAB-57NsAB-87 complex refined with 1 
B-factor per residue and colored on the same scale as in (A). (D-E) Average B-factors per 
protein chain for the CNCNsAB-57 complex (D) or CNCNsAB-57NsAB-87 complex (E). 
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(F-G). Paired refinement analysis of the resolution limit as described by Karplus and 
Diederichs (25) for the (F) CNCNsAB-57 complex or (G) CNCNsAB-57NsAB-87 
complex. The improvement in R-factors gained for each 0.2 Å shell of data was assessed 
by re-calculating the R-factors in the lower resolution data after refinement with the 
higher resolution data. 
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Fig. S6. 
Comparison of the yeast CNC structures from different crystal forms. (A) The 
structures of the CNCNsAB-57 complex (blue) and CNCNsAB-57NsAB-87 complex 
(orange) are shown alone and superimposed over the central Sec13NNup145C core. A 
view rotated by 90° is shown below. (B) Superposition of previously determined 
structures of the Nup120NTD C74 '42
N"D?
N"D?NTD hetero-trimer and the 
'47
N"D??08ADB435>A<>;42D;0AA4?;024<4=CPDB ID 3F7F, 3IKO, and 3F3F) (6, 8, 
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9) with their counterparts from the final crystallographic model. Cartoon representations 
are colored as in Fig. 1, whereas previous structures are colored in gray. Calculated root 
mean square displacements (rmsds) are indicated for each molecule. Nup85 has a large 
rmsd due to a large kink in the helical solenoid. Notably, crystal packing interactions of 
sAB-87 induce a slight rotation of the central triskelion. 
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Fig. S7. 
Biochemical characterization of the yeast CNC triskelion. (A-C) Nup120 interactions. 
Gel filtration profiles for Nup120 (A-C, blue), Nup85CTD (A, red), Sec13Nup145C126-712 
(B, red) and Sec13Nup145C126-556 (C, red) and after pre-incubation (green). (D-E) 
Seh1Nup85 interactions. Gel filtration profiles for Seh1Nup85 (D-E, blue), 
Sec13Nup145C75-712 (D, red), Sec13Nup145C126-712 (E, red) and after pre-incubation 
(green). (F) Interaction analysis between Nup85CTD and Nup145C. Gel filtration profiles 
for SUMO-Nup85CTD (blue) and SUMO-Nup145C75-109 alone (red) and after pre-
incubation (green). Gray bars in the gel filtration profiles indicate the fractions resolved 
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on the SDS-PAGE gels. Molecular mass standards and the positions of the proteins are 
indicated. Asterisks indicate degradation products. SDS-PAGE gels were stained with 
Coomassie brilliant blue. This size exclusion chromatography data is in agreement with 
previously published mass spectrometry data, which reported cross-links between 
Nup120K972 and Nup145CK672,K681,K694, Nup120K943 and Nup145CK681, and Nup120K972 
and Nup85K772,K733,K734 (12). 
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Fig. S8. 
Nup120NTD forms no interactions with Nup84NTD, Seh1Nup85, or 
Sec13Nup145C75-712. (A-C) Gel filtration profiles for the proteins alone: Nup120NTD 
(A-C, blue), Nup84NTD (A, red), Seh1Nup85 (B, red) and Sec13Nup145C75-712 (C, red) 
and after pre-incubation of the different complexes (green). Gray bars in the gel filtration 
profiles indicate the fractions resolved on the SDS-PAGE gels. Molecular mass standards 
and the positions of the proteins are indicated. Asterisks indicate degradation products. 
SDS-PAGE gels were stained with Coomassie brilliant blue. 
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Fig. S9.  
Seh1Nup85NTD forms no interactions with Nup84NTD, Nup120 or Sec13Nup145C75-
712. (A-C) Gel filtration profiles of Seh1Nup85NTD (A-C, blue), Nup120 (A, red), 
Sec13Nup145C75-712 (B, red), Nup84NTD (C, red) and after pre-incubation (green). Gray 
bars in the gel filtration profiles indicate the fractions resolved on the SDS-PAGE gels. 
Molecular mass standards and the positions of the proteins are indicated. Asterisks 
indicate degradation products. SDS-PAGE gels were stained with Coomassie brilliant 
blue. 
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Fig. S10. 
Synthetic antibody (sAB) interactions. (A) sAB-57 interacts with Seh1Nup85. Gel 
filtration profiles for Seh1Nup85 (blue), Seh1Nup85 preincubated with sAB-57 
(green). (B) sAB-57 interacts with Seh1Nup85Nup145C1-123. Gel filtration profiles for 
Seh1Nup85Nup145C1-123 (blue), Seh1Nup85Nup145C1-123 preincubated with sAB-
57 (green). Although sAB-57 can weakly interact with Seh1Nup85 (A), the interaction 
is only stoichiometric in the presence of Nup145C1-123 (B). (C) sAB-87 interacts with 
Nup120NTD. Gel filtration profiles for Nup120NTD (blue) and Nup120NTD pre-incubated 
with sAB-87 (green). Notably, sAB-57 and sAB-87 non-specifically interact with the 
Superdex 200 resin in the tested buffer conditions and were thus not analyzed in 
isolation. Gray bars in the gel filtration profiles indicate the fractions resolved on the 
SDS-PAGE gels. Molecular mass standards and the positions of the proteins are 
indicated. Asterisks indicate degradation products. SDS-PAGE gels were stained with 
Coomassie brilliant blue. 
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Fig. S11. 
Comparison of the yeast CNC crystal structure and its negative-stain EM 
reconstruction. Two views of the crystal structure, colored as in Fig. 1, superimposed on 
the negative-stain EM reconstruction (EMDB-5151 (4)) shown as a gray surface. Portions 
of the EM reconstruction are shaded green or cyan to indicate components of the complex 
that were not crystallized. 
  
 24 
 
 
Fig. S12. 
EM docking statistics. (A) The top 200 solutions (out of several thousands) plotted by 
ranked solution number and score. Top scoring solutions after refinement and rescoring 
with UCSF Chimera Fit in Map analysis are highlighted. (B) The top 65 solutions which 
showed a clear separation from the remaining solutions were refined and rescored with 
the UCSF Chimera Fit in Map tool. The highest 32 scoring solutions could be separated 
into four groups related by eight-fold rotational symmetry and are colored accordingly. 
The next highest scoring group of solutions, which clash with the top 32 solutions, is 
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colored in yellow. (C) Analysis of the next highest group of solutions. A member from 
each of the top scoring group of solutions is shown in cartoon representation, colored as 
in (A). The third solution clashes with the top two solutions, which are compatible with 
one another. (D) Comparison of the nucleoplasmic and cytoplasmic rings. Top and side 
views for the two faces of the NPC are shown with the members of each ring docked into 
the EM envelope. A superposition of the two rings without the EM density is shown on 
the right, which highlights the identical arrangement of CNCs despite no a priori 
information in the map restricting them to be the same. 
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Fig. S13. 
EM docking. A side view of the NPC is shown from within the central channel, 
highlighting the placement of 32 CNCs to the nuclear and cytoplasmic densities in the 
cryo-electron tomography reconstruction of the human NPC. The subunit organization of 
the inner ring remains unknown. 
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Table S1. 
Bacterial expression constructs 
 
Protein Residues Expression vector Restriction sites N-terminal overhang C-terminal overhang Reference 
Nup120t, ‡ 1-1037 pET8c NdeI, NotI MGSSHHHHHHSD None Lutzmann et al. 
Nup145C 75-712 pETDuet1 BamHI, NotI MGSSHHHHHHSQDP None This work 
Sec13t, ‡ 1-297  NdeI, XhoI None None  
Nup145C 75-556 pETDuet1 BamHI, NotI MGSSHHHHHHSQDP None This work 
Sec13 1-297  NdeI, XhoI None None  
Nup145C 126-712 pETDuet1 BamHI, NotI MGSSHHHHHHSQDP None This work 
Sec13 1-297  NdeI, XhoI None None  
Nup145CNTD 126-556 pETDuet1 BamHI, NotI MGSSHHHHHHSQDP None Nagy et al. 
Sec13 1-297  NdeI, XhoI None None  
Nup85 44-744 pETDuet1 NdeI, NotI MGSSHHHHHHSQDP None This work 
Seh1t, ‡ 1-349  NheI, XhoI None None  
Nup85NTD 1-570 pETDuet1 NdeI, NotI MGSSHHHHHHSQDP None Debler et al. 
Seh1 1-349  NheI, XhoI None None  
Nup85CTD 533-744 pET-MCN-SUMO BamHI, NotI S None This work 
Nup84NTDt 1-451 pET28a-PreS NdeI, NotI GPH None This work 
Nup84NTD‡ 
 
 
1-451 
 
 
pET28a-PreS-avi 
 
 
NdeI, NotI 
 
 
MGSSHHHHHHSSGLEVL
FQGPLMSGLNDIFEAQKI
EWHEGSAGGSGHM 
None 
 
 
This work 
 
 
Nup145C 75-109 pET-MCN-SUMO BamHI, NotI S None This work 
Nup145C 1-123 pET28a-SUMO BamHI, NotI S None This work 
Nup120NTD‡ 1-721 pGEX-4T1-TEV BamHI, NotI GAMGS None Seo et al. 
Nup120NTD‡ 
 
1-721 
 
pGEX-4T1-TEV-avi 
 
BamHI, NotI 
 
GAMGSSGLNDIFEAQKIE
WHEGSAGGSGGS 
None 
 
This work 
 
sAB-57 LC 
sAB-57 HCt 
1-217 
1-271 
pSFV4 
 
NcoI, Sal1 
 
None 
 
VDKKVEPKSCDKT
HTGGSHHHHHH 
This work 
 
sAB-87 LC  
sAB-87 HCt 
1-217 
1-267 
pSFV4 
 
NcoI, Sal1 
 
None 
 
VDKKVEPKSCDKT
HTGGSHHHHHH 
This work 
 
t Constructs that were used for crystallization of the coat nucleoporin complex 
‡ Constructs that were used for sAB selection 
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Table S2. 
Crystallographic analysis 
 
    
Data collection  SeMet/K2OsCl6 Ta6Br12 
Protein -40BC"NB-57 -40BC"NB-NB-87 -40BC"NB-NB-87 
Synchrotron APSa APSa APSa 
Beamline 23-ID-D 23-ID-D 23-ID-D 
Space group C2 P212121 P212121 
Cell dimensions    
    a, b, c (Å) 211.2, 186.4, 199.8 117.1, 180.0, 441.2 113.0, 175.8, 442.6 
    α, β, γ (°) 90.0, 100.9, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
    
Wavelength 0.9794 0.9794 1.2548 
Resolution (Å) 70.0 – 7.4 50.0 – 7.6 50.0 – 10.4 
Rmeas (%)b 10.1 (212.5) 10.8 (121.4) 14.9 (134.7) 
CC1/2 99.9 (51.8) 99.9 (60.6) 99.7 (80.3) 
< I / σI >b 15.3 (1.4) 13.5 (1.8) 6.4 (1.6) 
Completeness (%)b 99.0 (94.9) 99.2 (97.7) 99.0 (100.0) 
No. of observations 139,658 167,573 45,583 
No. of unique reflectionsb 10,375 (1,578) 22,082 (3,431) 8,095 (1,062) 
Redundancya 13.5 (13.5)  7.0 (7.0)  5.6 (5.7)  
    
Refinement    
Resolution (Å) 70.0 – 7.4 50.0 – 7.6  
No. of reflections 10,227 22,065  
No. of reflections test set 1,022 (10.0 %) 2,193 (9.9 %)  
Rwork / Rfree 33.0 / 35.3 31.8 / 34.7  
No. Protein atoms 26,147 19,824  
R.m.s deviations    
    Bond lengths (Å) 0.006 0.005  
    Bond angles (°) 1.2 1.1  
B-factorsc 716.5 536.5  
Ramachandran plotd    
    Favored (%) 91.0 91.9  
    Additionally allowed (%) 7.3 6.4  
    Outliers (%) 1.7 1.8  
    
aAPS, Advanced Photon Source 
bHighest-resolution shell is shown in parentheses 
cB-factors include overall B-factor of the crystal 
dAs determined by MolProbity (26) 
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Movie S1. 
Rotating structure of the yeast CNC in cartoon representation. The yeast CNC is colored 
according to Fig. 1. 
 
Movie S2. 
Rotating structure of the yeast CNC docked into the negative-stain EM reconstruction of 
the yeast CNC. The envelope of the EM reconstruction is shown in gray and the yeast 
CNC is colored according to Fig. 1. 
 
Movie S3. 
Rotating structure of the yeast CNC docked into the negative-stain EM reconstruction of 
the human CNC. The envelope of the EM reconstruction is shown in gray and the yeast 
CNC is colored according to Fig. 1. 
 
Movie S4. 
Architecture of the nuclear pore complex coat. Details as discussed in the text. The movie 
starts with an orientation of the NPC in the same orientation as in Fig. 4A. 
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